Mark Layton Selected Research

Mark Layton Research Topics

Disease

5	Rheumatoid Arthritis 11/2020 - 11/2010
4	Pain (Aches) 11/2020 - 06/2016
3	Sickle Cell Anemia (Hemoglobin S Disease) 08/2023 - 01/2016
2	Glucosephosphate Dehydrogenase Deficiency 10/2023 - 01/2021
2	Cognitive Dysfunction 01/2023 - 01/2022
2	Neoplasms (Cancer) 01/2021 - 07/2016
2	Cough 11/2020 - 10/2020
2	Rheumatic Diseases (Rheumatism) 11/2020 - 11/2020
2	Nasopharyngitis 11/2020 - 10/2020
1	Hemolysis 08/2023
1	Transfusion Reaction 08/2023
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 08/2023
1	COVID-19 01/2023
1	Inflammation (Inflammations) 01/2023
1	Pneumonia (Pneumonitis) 01/2023
1	Respiratory Insufficiency (Respiratory Failure) 01/2023
1	Cerebral Infarction 01/2022
1	Vivax Malaria 01/2021
1	Leiomyoma (Uterine Fibroids) 11/2020
1	Osteitis 11/2020
1	Synovitis 11/2020
1	Spasm (Spasms) 11/2020
1	Dizziness (Lightheadedness) 11/2020
1	Myocardial Infarction 11/2020
1	Ankle Fractures 11/2020
1	Pyelonephritis 11/2020
1	Arthralgia (Joint Pain) 11/2020
1	Osteoarthritis 10/2020
1	Neuralgia (Stump Neuralgia) 06/2016
1	Congenital Pain Insensitivity 06/2016
1	Paroxysmal Extreme Pain Disorder 06/2016
1	Acute Pain 01/2016
1	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 04/2013
1	Blister (Bulla) 08/2007
1	Bone Resorption 09/2004
1	Monoclonal Gammopathy of Undetermined Significance 09/2004

Drug/Important Bio-Agent (IBA)

5	Methotrexate (Mexate)FDA LinkGeneric 11/2020 - 11/2010
4	OtilimabIBA 01/2023 - 10/2020
4	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2023 - 10/2020
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 11/2020
2	Sulfasalazine (Azulfidine)FDA LinkGeneric 10/2012 - 05/2011
2	AZD9056IBA 10/2012 - 05/2011
1	tafenoquineIBA 10/2023
1	Antimalarials (Antimalarial Agents)IBA 10/2023
1	Primaquine FDA Link 10/2023
1	Complement System Proteins (Complement)IBA 08/2023
1	eculizumab FDA Link 08/2023
1	AntibodiesIBA 08/2023
1	Monoclonal AntibodiesIBA 01/2023
1	C-Reactive ProteinIBA 01/2023
1	Ferritins (Ferritin)IBA 01/2023
1	Hemoglobins (Hemoglobin)IBA 01/2023
1	Oxygen (Dioxygen)IBA 01/2022
1	Glucosephosphate Dehydrogenase (Glucose 6 Phosphate Dehydrogenase)IBA 01/2021
1	rasburicase (Elitek)FDA Link 01/2021
1	CC ChemokinesIBA 11/2020
1	LigandsIBA 11/2020
1	PerforinIBA 07/2016
1	NAV1.7 Voltage-Gated Sodium ChannelIBA 06/2016
1	Morphine (MS Contin)FDA LinkGeneric 01/2016
1	Ibuprofen (Motrin)FDA LinkGeneric 01/2016
1	Opioid Analgesics (Opioids)IBA 01/2016
1	Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)IBA 04/2013
1	Purinergic Receptors (Receptors, Purine)IBA 10/2012
1	N- (1- (3- (3,5- difluorophenyl)- 3- (4- methanesulfonylphenyl)propyl)piperidin- 4- yl)- N- ethyl- 2- (4- methanesulfonylphenyl)acetamideIBA 11/2010
1	Chemokine ReceptorsIBA 11/2010
1	AutoantigensIBA 08/2007
1	Collagen Type I (Type I Collagen)IBA 09/2004
1	OsteoprotegerinIBA 09/2004
1	RANK LigandIBA 09/2004
1	Chemokine CCL3IBA 09/2004
1	Alkaline PhosphataseIBA 09/2004
1	Tartrate-Resistant Acid PhosphataseIBA 09/2004
1	collagen type I trimeric cross-linked peptideIBA 09/2004
1	Proteins (Proteins, Gene)FDA Link 09/2004

Therapy/Procedure

2	Therapeutics 01/2021 - 05/2011
1	Intravenous Infusions 01/2023
1	Patient-Controlled Analgesia (Analgesia, Patient Controlled) 01/2016